Connect with us

Business

Chimeric (ASX:CHM) share price drops despite cancer trial update

Published

on

Image Source: Getty Images

The Chimeric Therapeutics Ltd (ASX: CHM) share price has fallen today. It coincides with the drug development company’s update on its cancer cell therapy.

At market’s close, the Chimeric share price was trading at 29 cents, down…



Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending